Literature DB >> 2658754

Genetic changes in the pathogenesis of lung cancer.

M J Birrer1, J D Minna.   

Abstract

Human lung cancer is a complex genetic disease resulting from a series of inherited and somatically occurring defects in a number of critical genes. These genetic events, produced in part by carcinogen exposure, include chromosomal deletion, rearrangement, and mutation, and lead to inactivation or activation of certain target genes. Recent data showed these genes to include both recessive oncogenes such as the retinoblastoma gene and dominantly acting oncogenes such as the myc and ras family members.

Entities:  

Mesh:

Year:  1989        PMID: 2658754     DOI: 10.1146/annurev.me.40.020189.001513

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  4 in total

1.  Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma.

Authors:  C L Williams; V A Lennon
Journal:  Cell Regul       Date:  1991-05

Review 2.  Molecular mechanisms of cancer.

Authors:  H P Koeffler; F McCormick; C Denny
Journal:  West J Med       Date:  1991-11

3.  Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression.

Authors:  Thomas E Sussan; Mathew T Pletcher; Yoshinori Murakami; Roger H Reeves
Journal:  Mol Cancer       Date:  2005-08-05       Impact factor: 27.401

4.  Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.

Authors:  K Rygaard; T Nakamura; M Spang-Thomsen
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.